— Know what they know.
Not Investment Advice
Also trades as: MEDCL.PA (PAR) · $vol 2M

MDCLF OTC

MedinCell S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +392.7% 1Y: +392.7% 3Y: +254.5%
$34.39
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 48 · $1.2B mcap · 26M float · 0.0000% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$108M +19.5% ▲
5Y CAGR: +11.2%
Total Liabilities
$105M -1.7% ▼
5Y CAGR: +13.9%
Shareholders Equity
$3M +118.7% ▲
5Y CAGR: -19.2%
Cash & Investments
$85M +18.0% ▲
5Y CAGR: +11.2%
Total Debt
$57M -2.3% ▼
5Y CAGR: +5.8%
Net Debt
-$5M -1794.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$25M$6M$19M$59M$63M
Short-Term Investments$2M$0$0$13M$22M
Cash & ST Investments$27M$6M$19M$72M$85M
Net Receivables$819K$2M$2M$3M$5M
Inventory$0$760K-$19K$0$0
Other Current Assets$6M$10M$5M$6M$7M
Total Current Assets$34M$20M$27M$81M$97M
Property, Plant & Equip.$7M$6M$5M$5M$0
Goodwill & Intangibles$2M$2M$2M$3M$3M
Long-Term Investments-$2M$454K$1M$0$27K
Other Non-Current Assets$3M$1M$536K$2M$8M
Total Non-Current Assets$10M$10M$10M$10M$11M
Total Assets$44M$29M$37M$90M$108M
— Liabilities —
Accounts Payable$3M$4M$2M$4M$3M
Short-Term Debt$28M$43M$6M$7M$3M
Deferred Revenue$7M$9M$0$0$0
Other Current Liabilities-$1M$7M$5M$18M$14M
Total Current Liabilities$38M$57M$16M$30M$21M
Long-Term Debt$16M$12M$51M$49M$52M
Other Non-Current Liab.$287K$356K$9M$25M$30M
Total Non-Current Liabilities$19M$15M$61M$77M$84M
Total Liabilities$58M$72M$78M$107M$105M
— Equity —
Common Stock$251K$253K$291K$331K$359K
Retained Earnings-$25M-$32M-$25M-$18M-$31M
Accumulated OCI-$21M-$50M-$47M$0-$11M
Total Stockholders Equity-$13M-$42M-$41M-$16M$3M
Total Liabilities & Equity$44M$29M$37M$90M$108M
— Key Metrics —
Total Debt$47M$58M$59M$59M$57M
Net Debt$23M$51M$40M-$284K-$5M
Total Investments$145K$454K$1M$13M$22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms